No PHI 15-minute fit review for GLP-1 clinics
Evaluate a synthetic weekly queue for GLP-1 follow-up operations.
PulseLog by HealthPulseAI gives weight-loss, primary-care, DPC, metabolic, and medspa teams a synthetic-only way to evaluate how a weekly follow-up queue could fit their operations.
The review and 30-day pilot use synthetic examples and aggregate operational ranges only. Real patient data, patient-derived aliases, PHI, production storage, and live clinic workflows are out of scope.
30-day pilot shape
1 clinic / 1 workflow / 20 synthetic rows
The full 30-day pilot remains synthetic-only; it does not graduate to patient-level data.
- • Weekly green/yellow/red intervention queue
- • Side-effect, hydration, and confidence risk trends
- • Refill/access and coverage-friction report
- • Staff action readout and continuation recommendation
Why this wedge is urgent now
A 2025 JAMA Network Open cohort study of adults with overweight or obesity reported that most patients discontinued GLP-1 therapy within one year, with higher discontinuation among patients without type 2 diabetes. Clinics do not need another broad wellness app; they need earlier signals that a patient is about to miss, pause, ration, or abandon therapy.
Source: JAMA Network Open, Discontinuation and Reinitiation of GLP-1 Receptor AgonistsSynthetic queue mockup
Staff evaluate how a fixed queue would organize follow-up signals.
Example rows below are synthetic row IDs. They illustrate the staff workflow without exposing patient names, contact details, prescription identifiers, or clinical notes.
SYN-014Red
Signal: Missed dose + dehydration concern
Next action: Clinician escalation policy
SYN-022Yellow
Signal: Refill/access issue
Next action: Staff access check
SYN-031Yellow
Signal: Nausea score increased
Next action: Side-effect protocol review
SYN-047Green
Signal: Dose taken, confidence stable
Next action: Routine encouragement
What the first pilot can include
- • Synthetic row ID only
- • Medication family
- • Dose phase
- • Dose taken / missed / delayed
- • Side-effect severity bands
- • Refill, access, and coverage friction
- • Confidence score
- • Staff follow-up requested
What must stay out of the first request
- • Names or initials
- • Date of birth
- • MRN or prescription IDs
- • Phone numbers or emails
- • Addresses or member IDs
- • Screenshots or portal messages
- • Free-text clinical notes
After you request a review
The first step is a 15-minute no-PHI fit review, not a data handoff.
Clinic teams get a clear operating discussion before any pilot is approved: who owns follow-up, which non-identifying signals matter, and whether a 30-day PulseLog pilot is worth scoping.
1. Confirm the workflow owner
Identify who owns between-visit GLP-1 follow-up without sending patient charts, exports, or screenshots.
2. Map the no-PHI pilot queue
Use synthetic examples to choose the refill, side-effect, access, and confidence signals staff would review weekly.
3. Decide on the 30-day pilot fit
Leave with a scoped go/no-go note and next-step owner for a synthetic-only pilot.
Onsite fit-review request
Request the PulseLog GLP-1 pilot packet without leaving this page.
Share clinic-level workflow context only. The request is saved to the existing pilot lead queue so the review does not depend on a local email application opening successfully.
Want the 30-day pilot packet?
We will review fit and clinic workflow for a synthetic-only, no-PHI pilot. Real patient data and production workflows remain out of scope. Do not include PHI in the public request.
Request GLP-1 pilot review